20-18306378-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001352452.2(ZNF133):āc.202C>Gā(p.Pro68Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000103 in 1,613,424 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001352452.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF133 | NM_001352452.2 | c.202C>G | p.Pro68Ala | missense_variant | 6/7 | ENST00000425686.3 | NP_001339381.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF133 | ENST00000425686.3 | c.202C>G | p.Pro68Ala | missense_variant | 6/7 | 3 | NM_001352452.2 | ENSP00000406638 | A2 | |
ENST00000666293.1 | n.426-16349G>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000360 AC: 9AN: 249810Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 134976
GnomAD4 exome AF: 0.000103 AC: 150AN: 1461152Hom.: 0 Cov.: 31 AF XY: 0.0000949 AC XY: 69AN XY: 726788
GnomAD4 genome AF: 0.000105 AC: 16AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 07, 2022 | The c.202C>G (p.P68A) alteration is located in exon 6 (coding exon 2) of the ZNF133 gene. This alteration results from a C to G substitution at nucleotide position 202, causing the proline (P) at amino acid position 68 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at